Characterization of Conformation and Dynamics of CD4 Fragment (81-92) TYICEVEDQKEE and Its Benzylated Derivative by 1H NMR Spectroscopy and Molecular Modeling: Relevance of Conformation to Biological Function

Journal of Acquired Immune Deficiency Syndromes

Volumn 11, Issue 3, 1996, Pages 222-232

  Chang, Ding Kwo ^a   Chien, Wei Jyun ^a   Cheng, Shu Fang ^a  

^a INSTITUTE OF CHEMISTRY   (Taiwan)

Author keywords

Correlation time; Distance geometry ; Envelope glycoprotein ; Hydrophobic interaction ; Simulated annealing ; turn

Indexed keywords

CD4 ANTIGEN; CELL SURFACE MARKER; GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; IMMUNE RESPONSE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, CD4; ANTIVIRAL AGENTS; BENZYL COMPOUNDS; COMPUTER SIMULATION; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION;

EID: 1842614429     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199603010-00002     Document Type: Article

References (38)

1. Eichmann K, Jönsson JI, Falk I, Emmrich F. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4. Eur J Immunol 1987;17:643-50.
2. Maddon P, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobin gene family. Cell 1985;42:93-104.
3. Wang J, Van Y, Garrett TP, Liu JJ, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990;348:411-8.
4. Ryu S-E, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai X, Xuong N-H, Axel R, Sweet RW, Hendrickson WA. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 1990;348:419-26.
5. Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Freeman GA, Nusinoff-Lehman S, Bolognesi DP, Broder S, Mitsuya H, Barry DW. Phosphorylation of 3′-azido-3′ deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 1986;83:8333-7.
6. Arthos J, Deen CK, Chaikin MA, Fornwald JA, Sattentau QJ, Clapham PR, Weiss RA, McDougal JS, Pietropaolo C, Maddon PJ, Truneh A, Axel R, Sweet RW. Identification of the residues in human CD4 critical for the binding of HIV. Cell 1989;57:469-81.
7. Peterson A, Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 1988;54:65-72.
8. Lifson JD, Hwang KM, Nara PL, Fraser B, Padgett M, Dunlop NM, Eiden LE. Synthetic CM peptide derivatives that inhibit HIV infection and cytopathicity. Science 1988;241: 712-6.
9. Brodsky MH, Walton M, Myers RM, Littman DR. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 1990;144:3078-86.
10. Chany C, Chany-Fournier F, Robain O. Cell fusion in viral disease. Nature 1987;326:250.
11. Lifson JD, Reyes GR, McGrath MS, Stein BS, Engelman EC. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986;232: 1123-7.
12. Traunecker A, Luck W, Karjalainen K. Soluble CD4 molecules neutralize human immunodeficiency virus type I. Nature 1988;331:84-6.
13. Smith DH, Byrn RA, Marsters SA, Gregory T, Groopman JE, Capon DJ. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 1987;238:1704-7.
14. Nara PL, Hwang KM, Rausch DM, Lifson JD, Eiden LE. CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of viral life cycle. Proc Natl Acad Sci USA 1989;86:7139-43.
15. Hayashi Y, Ikuta K, Fujii N, Ezawa K, Kato S. Inhibition of HIV-1 replication and syncytium formation by synthetic CD4 peptides. Arch Virol 1989;105;129-35.
16. Lasarte JJ, Sarobe P, Golvano J, Prieto I, Civeira MP, Gullon A, Sarin PS, Borras-Cuesta FJ. CD4-modified synthetic peptides containing phenylalanine inhibit HIV-1 infection in vitro. J Acquir Immune Defic Syndr 1994;7:129-34.
17. Nara PL, Garrity RR, Goudsmit J. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J 1991;5:2437-55.
18. Batinic D, Robey F. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem 1992;267:6664-71.
19. Chang DK, Liang CC. Influence of bulky side chains of amino acids on the solution conformation of peptide fragment (81-92) derivatives of CD4, TYICEVEDQKEE, as studied by NMR spectroscopy and molecular modeling. Biochim Biophys Acta 1994;1205:262-7.
20. 1H spin-spin coupling constants in protein. Biochem Biophys Res Commun 1983;113:967-74.
21. Braunschweiler L, Ernst RR. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J Magn Reson 1983;53:521-8.
22. Ernst RR, Bodenhausen G, Wokaun A. Principles of nuclear magnetic resonance in one and two dimensions. Oxford: Clarendon Press, 1987:506-8.
23. 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun 1983;117:479-85.
24. Karplus M. Contact electron-spin coupling of nuclear magnetic moments. J Chem Phys 1959;30:11-5.
25. Havel TF, Kuntz ID, Crippen GM. The theory and practice of distance geometry. Bull Math Biol 1983;45:665-720.
26. Nilges M, Clore GM, Gronenborn AM. Determination of three-dimensional structure of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett 1988;229:317-24.
27. Wüthrich K. NMR of proteins and nucleic acids. New York: Wiley, 1986:166.
28. Tanford C. The Hydrophobic effect: formation of micelles and biological membranes. New York: Wiley, 1980.
29. Wilmot CM, Thornton JM. β-Turns and their distortions: a proposed new nomenclature. Protein Eng 1990;3:479-93.
30. Noggle JH, Schirmer RE. The nuclear Overhauser effect. New York: Academic Press, 1971.
31. Abragam A. The principles of nuclear magnetism. Oxford: Clarendon Press, 1961.
32. Kalyanaraman VS, Rausch DM, Osborne J, Padgett M, Hwang KM, Lifson JD, Eiden LE. Evidence by peptide mapping that the region CD4(81-92) is involved in gpl20/ CD4 interaction leading to HIV infection and HIV-induced syncytium formation. J Immunol 1990;145:4072-8.
33. Broder CC, Berger EA. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type I envelope glycoprotein-mediated cell fusion. J Virol 1993;67:913-26.
34. Lifson JD, Rausch DM, Kalyanaraman VS, Huang KM, Eiden LE. Synthetic peptides allow discrimination of structural features of CD4(81-92) important for HIV-1-induced syncytium formation. AIDS Res Hum Retrovirus 1991;7: 521-7.
35. Berger EA, Lifson JD, Eiden LE. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci USA 1991;88:8082-6.
36. Repke H, Gabuzda D, Palu G, Emmrich F, Sodroski J. Effect of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol 1992;149:1817-24.
37. Camerini D, Seed B. A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site. Cell 1990;60:747-54.
38. Eiden LE, Lifson JD. HIV interaction with CD4: a continuum of conformations and consequences. Immunol Today 1992;13:201-6.